Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase II Randomized Study of Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Summary

The purpose of this phase II study is to evaluate a combination of interventions as a possible treatment for pancreatic tumor. The interventions involved in this study are: - FOLFIRINOX which is made up of 4 different drugs: - 5-Fluorouracil (5-FU) - Oxaliplatin - Irinotecan - Leucovorin - Losartan - Nivolumab - Radiation Therapy - Surgery

General Information

NCT#: NCT03563248
Study ID: 18-179
Trial Phase: Phase II

Trial Sponsor: Bristol-Myers Squibb, Massachusetts General Hospital, SU2C - Stand Up to Cancer
Therapies Used in This Trial: Fluorouracil, Oxaliplatin, Stereotactic body radiotherapy (SBRT), Irinotecan, Leucovorin, Surgery, Losartan, Nivolumab, FOLFIRINOX

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search